SOURCE: Burrill & Company

Burrill & Company

April 12, 2012 12:05 ET

Chemical Heritage Foundation Honors Biotech Visionary G. Steven Burrill With Richard J. Bolte, Sr. Award for Supporting Industries for His Contributions in Helping Build the Biotechnology Industry

Burrill & Company CEO Recognized for Contributions Vital to the Growth and Development of Chemical and Molecular Sciences

SAN FRANCISCO, CA--(Marketwire - Apr 12, 2012) - G. Steven Burrill, a biotech industry visionary and CEO of Burrill & Company, today received the Richard J. Bolte, Sr. Award for Supporting Industries from the Chemical Heritage Foundation for his lifetime achievement in helping build the biotechnology industry globally.

The Chemical Heritage Foundation honored Burrill during its Heritage Day 2012 event in Philadelphia. Heritage Day is the Foundation's annual celebration of the achievements and promise of chemistry and related sciences. The independent, nonprofit organization fosters an understanding of chemistry's impact on society.

An early pioneer of the biotechnology industry, Burrill is one of its original architects and one of its most avid and sustained developers. He has worked within the biotech industry for more than 40 years and contributed to companies tackling the greatest challenges facing our world today, from the development of drugs to treat diseases without adequate therapies, to addressing the need to develop new and affordable sources of renewable energy.

"I am honored to receive this recognition from an organization that both preserves the historic scientific accomplishments of our industries and works to inspire passion for the chemical and molecular sciences," says G. Steven Burrill, CEO of Burrill & Company, a diversified global financial services firm focused on the life sciences industry.

Mr. Burrill currently serves on the boards of directors of AliveCor (Chairman), Catalyst Biosciences, Depomed, NewBridge, Novadaq, Targacept, and XDx. Previously he served as Chairman of the boards of BioImagene, Abunda Nutrition, and Pharmasset. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology, life sciences, high technology, and manufacturing industries worldwide.

In 1995 Mr. Burrill received BIO's service award for his global biotechnology leadership. In 2002 he was recognized as a biotech investment visionary by the prestigious Scientific American magazine (The Scientific American 50), and was also honored that year at the American Liver Foundation's Annual "Salute to Excellence" Gala, which honors the best and the brightest from the Bay Area's medical, biotech and biopharmaceutical industries. In 2008 he received the BayBio Pantheon DiNA lifetime achievement award for his worldwide biotech leadership; and in the same year he received the Alan Cranston Living Legend Award for his central role in advancing biomedical research globally. In 2011 he received a lifetime achievement award at Scrip Intelligence's annual Scrip Award ceremony in London; also in 2011 he received the Breath of Life Award from the Northern California Chapter of the Cystic Fibrosis Foundation to honor him for his contributions to the life sciences industry throughout his career.

In addition to his work with leading life science companies, Mr. Burrill is a founder and currently serves as Chairman of the board of the National Science and Technology Medals Foundation. Additionally, he serves as Chairman of the San Francisco Mayor's Biotech Advisory Committee. Mr. Burrill chaired the National Research Council study on linkages in biotechnology between Japan and the United States and was also involved with the U.S.-Japan Science and Technology Agreement Study of Technology Transfer Mechanisms between the U.S. and Japan. Other not-for-profit activities include serving on the boards of directors of the Life Science Foundation (Chairman); the World Council for Ethical Standards (Chairman); the Vilas County (Wisconsin) Economic Development Corporation (Chairman); the National Health Museum (Vice Chairman); the Bay Area Science Infrastructure Consortium; BayBio (Emeritus); California Healthcare Institute (Emeritus); The Exploratorium (Emeritus); The Kellogg Center for Biotechnology; the MIT Center for Biomedical Innovation; BIO Ventures for Global Health (BVGH); The Gladstone Foundation; the Harvard Medical School Genetics Advisory Council; and the NIH Scientific Management Review Board.

He serves on the editorial boards of Scientific American, the Journal of Commercial Biotechnology, and Life Science Leader and also serves on the advisory boards of the Center for Policy on Emerging Technologies and BioAg Gateway, City of Madison. He is an advisor to the University of Illinois Institute for Genomic Biology, the University of Wisconsin College of Agricultural and Life Sciences, the University of Minnesota College of Biological Sciences, Duke University, University of California, Davis, and is an adjunct professor at University of California, San Francisco. He also serves on the advisory boards for the Department of Biology at San Francisco State University and the Biotechnology Master's Program in the Department of Biology at the University of San Francisco. He serves on the BioNJ Diagnostics & Personalized Medicine Committee.

About Burrill & Company
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With $1.5 billion in assets under management, the firm's businesses include venture capital/private equity, merchant banking, and media. By leveraging the scientific and business networks of its team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, transactional support, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia. For more information visit: www.burrillandco.com.

Contact Information

  • Contact:
    Daniel Levine
    Managing Director
    Burrill & Company
    Email Contact
    415-591-5449